Discovery of 4-((2 <i>S</i> ,4 <i>S</i> )-4-Ethoxy-1-((5-methoxy-7-methyl-1 <i>H</i> -indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases
Nello Mainolfi(Akebia Therapeutics (United States)), Christopher M. Adams(Novartis (Switzerland)), Roland Feifel(Goethe University Frankfurt), Cornelia J. Forster(Novartis (United States)), Barbara Vogg(Novartis (Switzerland)), Michael Capparelli(Novartis (United States)), Catherine Solovay(Novartis (United States)), Eric Valeur(AstraZeneca (Sweden)), Stefanie Flohr(Novartis (Switzerland)), Luciana Ferrara(Novartis (United States)), Jörg Eder(Novartis (Switzerland)), James J. Powers(Novartis (United States)), Upendra A. Argikar(Novartis (United States)), Daniela Ostermeier(Novartis (Switzerland)), Frédéric Cumin(Novartis (Switzerland)), Finton Sirockin(Novartis (Switzerland)), Thomas M. Smith(Novartis (China)), R. A. Harrison, Maura Crowley(Novartis (United States)), Muneto Mogi, Daniel W. Klosowski(Novartis (United States)), A. De Erkenez(Novartis (United States)), Bernd Gerhartz(Novartis (Switzerland)), Melissa Prentiss(Novartis (United States)), A. Mac Sweeney(Novartis (Switzerland)), Christian Wiesmann(Novartis Institutes for BioMedical Research), Sha-Mei Liao(Novartis (China)), Myriam April(Novartis (United States)), Anna Schubart(Novartis (Switzerland)), Richard Sedrani(Novartis (Switzerland)), Bruce Jaffee(DuPont (United States)), Nathalie Gradoux(Novartis (Switzerland)), Takeru Ehara(Novartis (United States)), Holger Sellner(Novartis (Switzerland)), P. Erbel(Novartis (Switzerland)), Rajeshri G. Karki(Novartis (United States)), Paul Ramage(Novartis (Switzerland)), Michael H. Serrano‐Wu(Broad Institute), Fang Liu(Purdue University West Lafayette), Chun Zhang(Wenzhou Medical University), Jian Ding(Novartis (United States)), Wendy Lee(Alzheimer's Association), Debby Long(Novartis (United States)), Karen Anderson(Novartis (United States)), Toshio Kawanami(Novartis (United States)), Jürgen Maibaum(Novartis (Switzerland)), R. Ramqaj(Novartis (Switzerland)), Louis Yang(Novartis (United States)), Keith Jendza(Novartis (United States))
Cited by 61
Related Papers
Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
|Nature|1995|968
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
|Nature|2010|940
Migratory Properties of Naive, Effector, and Memory Cd8+ T Cells
|The Journal of Experimental Medicine|2001|519
Inhibition of Mitogen-Activated Protein Kinase Kinase Blocks T Cell Proliferation But Does Not Induce or Prevent Anergy
|The Journal of Immunology|1998|294
Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell–cell adhesion and signaling mechanism that requires <i>cis-trans</i> receptor clustering
|Proceedings of the National Academy of Sciences|2012|213